期刊文献+

GW2974对实验性口腔癌中EGFR及p-EGFR表达的抑制作用研究

Inhibitng effects of GW2974 on EGFR and p-EGFR in DMBA-induced hamster buccal pouch carcinogenesis model.
原文传递
导出
摘要 目的:观察小分子酪氨酸激酶抑制剂GW2974对实验性口腔癌中EGFR及p-EGFR表达的抑制作用。方法:选取100只金黄地鼠,其中10只为阴性对照,其余90只于左侧颊囊涂0.5%DMBA,每周3次。6周后实验组随机分为阳性对照组、GW2974低浓度组、GW2974高浓度组。阳性对照组不做处理,其余两组于左侧颊囊涂抹不同浓度的GW2974(4mM/L,mM/L)。24周末处死所有动物,取左侧颊囊黏膜,用免疫组化方法检测各组癌灶中EGFR及p-8EGFR表达情况。结果:通过局部应用4mM/L和8mM/L的GW2974,用药后p-EGFR表达水平均降低,呈现一定的剂量-效应关系;而EGFR的表达未见明显变化。结论:GW2974可以明显抑制实验性口腔癌中p-EGFR的表达,即抑制EGFR的活化,但对EGFR的表达影响不大。GW2974可能通过抑制EGFR胞内区酪氨酸激酶的活化,进而抑制癌细胞EGFR/ErbB2的磷酸化作用,从而达到抑制口腔癌发生的目的。 Objective:To study the inhibiting effects of GW2974,a tyrosine kinase inhibitors (TKIs),on EGFR and p-EGFR in DMBA-induced hamster buccal pouch carcinogenesis model. Method:10 male Syrian golden hamsters served as negative control. The left buccal pouches of 90 hamsters were painted with 0.5% DMBA three times a week for 6 weeks. Afterwards, they were divided into 3 groups according to mean body weight,including positive control and two differently treated groups. Positive control received no further treatment. The two differently treated groups were continuously topically painted with 4mM/L GW2974 and 8mM/L GW2974 three times a week,respectively. Tissue samples of the left cheek pouch were obtained at the 24 th week. The various expression of EGFR,p-EGFR in specimens of each group were detected by immunohistochemical staining. Result:After GW2974(4 mM/L and 8 mM/L) applied topically,the expression of p-EGFR declined significantly (P〈0.05) in a dose-dependent manner, but there was no significant difference on the expression of EGFR. Conclusion:GW2974 applied topically can inhibit the expression of p-EGFR in an oral cancer model, but not the expression of EGFR. These findings suggested that GW2974 may interfere in the downstream signaling pathway of EGFR via c-Fos and c-Jun,which results in inhibiting tumor cell proliferation and oral cancinogenesis. The results indicated that GW2974 applied topically can inhibit activation but not the expression of EGFR. It indicated that GW2974 may prevent phosphorylation EGFR/ErbB2,which resulted in inhibiting tumor cell proliferation and oral cancinogenesis.
出处 《临床口腔医学杂志》 2008年第2期75-78,共4页 Journal of Clinical Stomatology
关键词 口腔癌 表皮生长因子受体 酪氨酸激酶抑制剂 oral cancer epidermal growth factor receptor(EGFR) hamster buccal pouch carcinogenesis tyrosine kinase inhibitors(TKIs)
  • 相关文献

参考文献14

  • 1Parker SL,Tong T,Bolden S,et al.Cancer statistics 1996[J].CA Cancer J Clin.1996,46 (1):5-27.
  • 2Putti TC,To KF,Hsu HC,et al.Expression of epidermal growth fac-tor receptor in head and neck cancers correlates with clinical pro-gression.,a multicentre inununohistochemical study in the Asia-Pa-cific region[J].Histopathology,2002,41 (2):144-151.
  • 3Rnsnak DW,Affleck K,Cockerill SG,et al.The characterization of novel,dual ErbB -2 / EGFR,tyresine kinase inhibitors:potential therapy for cancer[J].Cancer Res,2001,61(19):7196-203.
  • 4Eveson JW.Animal models of intra-oral chemical carcinogenesis:a review[J].J Oral Pathol,1981,10(3):129-146.
  • 5Ultrich A,Schlessinger J.Signal transduction by receptors with tyro-sine kinase activity[J].Cell,1990,61 (2):203-212.
  • 6de Jong JS,van Diest PJ,van der Valk P,et al.Expression of growth factors,growth factor receptors and apoptosis related proteins in in-vasive breast cancer:relation to apoptotic rate[J].Breast Cancer Res Treat,2001,66 (3):201-208.
  • 7Mendelsohn J,Baselga J.Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer[J].Clini Oncol,2003,21 (14):2787-99.
  • 8Gupta AK,McKenna WG,Weber CN,et al.Local recurrence in head and neck cancer:relationship to radiation resistance and signal trans-duction[J].Clin Cancer Res,2002,8(3):885-892.
  • 9Putti TC,To KF,Hsu HC,et al.Expression of epidermal growth fac-for receptor in head and neck cancers correlates with clinical pro-gression:a multicentre immunohistochemical study in the Asia-Pa-cific region[J].Histopathology,2002,41 (2):144-151.
  • 10Frampton JE,Easthope SE.Spotlight on gefitinib in non-small-cell lung cancer[J].Am J Pharmacogenomics,2005,5(2):133-136.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部